Amyloid-β neurotoxicity in organotypic culture is attenuated by melatonin: Involvement of GSK-3β, tau and neuroinflammation

Journal of Pineal Research

Volumn 48, Issue 3, 2010, Pages 230-238

  Hoppe, Juliana Bender ^a   Frozza, Rudimar Luiz ^a   Horn, Ana Paula ^a   Comiran, Ricardo Argenta ^a   Bernardi, Andressa ^a   Campos, Maria Martha ^b   Battastini, Ana Maria Oliveira ^a   Salbego, Christianne ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Alzheimer's disease; Amyloid peptide; GSK 3 ; Melatonin; Neuroinflammation; Organotypic culture; Tau protein

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; GSK 3 BETA ENZYME; INTERLEUKIN 6; MELATONIN; PROTEIN KINASE; TAU PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; HIPPOCAMPUS; MACROGLIA; MALE; MICROGLIA; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANALYSIS OF VARIANCE; ANIMALS; ASTROCYTES; CELL DEATH; GLYCOGEN SYNTHASE KINASE 3; HIPPOCAMPUS; HISTOCYTOCHEMISTRY; INTERLEUKIN-6; MALE; MELATONIN; NERVE TISSUE PROTEINS; PROPIDIUM; RATS; RATS, WISTAR; TAU PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77749336528     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2010.00747.x     Document Type: Article

References (65)

1. Tuppo E, Arias H. The role of inflammation in Alzheimer's disease. Int J Biochem Cell Biol 2005 37 : 289 305.
2. Selkoe DJ, Schenk D. Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol 2003 43 : 545 584.
3. Lee J, Lee Y, Yuk D, et al. Neuroinflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation. J Neuroinflammation 2008 5 : 1 14.
4. Akiyama H, Barger S, Barnum S, et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000 21 : 383 421.
5. Cheng G, Whitehead S, Hachinski V, et al. Effects of pyrrolidine dithiocarbamate on beta-amyloid (25-35)-induced inflammatory responses and memory deficits in the rat. Neurobiol Dis 2006 23 : 140 151.
6. Crespo-biel N, Canudas A, Pallàs M. Kainate induces AKT, ERK and cdk5/GSK3β pathway deregulation, phosphorylates tau protein in mouse hippocampus. Neurochem Int 2007 50 : 435 442.
7. Fuentealba R, Farias G, Scheu J, et al. Signal transduction during amyloid-β-peptide neurotoxicity: role in Alzheimer's disease. Brain Res Rev 2004 47 : 275 289.
8. Kins S, Beyreuther K. Teasing out the tangles. Nat Med 2006 12 : 764 765.
9. Sorrentino G, Bonavita K. Neurodegeneration and Alzheimer's disease: the lesson from tauopathies. Neurol Sci 2007 28 : 63 71.
10. Golde T. Inflammation takes on Alzheimer's disease. Nat Med 2002 8 : 936 938.
11. Wyss-coray T. Inflammation in Alzheimer's disease: driving force, bystander or beneficial response? Nat Med 2006 12 : 1005 1015.
12. Medeiros R, Prediger RD, Passos GF, et al. Connecting TNF-alpha signaling pathways to iNOS expression in a mouse model of Alzheimers' disease: relevance for the behavioral and synaptic deficits induced by amyloid beta protein. J Neurosci 2007 27 : 5394 5404.
13. Park KW, Lee HG, Jin BK, et al. Interleukin-10 endogenously expressed in microglia prevents lipopolysacharide-induced neurodegeneration in the rat cerebral cortex in vivo. Exp Mol Med 2007 39 : 812 819.
14. Guo J, Yu J, Grass D, et al. Inflammation-dependent cerebral deposition of serum amyloid a protein in a mouse model of amyloidosis. J Neurosci 2002 22 : 5900 5909.
15. Heneka MT, O'banion MK. Inflammatory processes in Alzheimer's disease. J Neuroimmunol 2007 184 : 69 91.
16. 1-42. J Pineal Res 2008 45 : 157 165.
17. Olcese JM, Chuanhai C, Mori T, et al. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer's disease. J Pineal Res 2009 47 : 82 96.
18. Matsuraba E, Bryant-thomas T, Quinto JP, et al. Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease. J Neurochem 2003 85 : 1101 1108.
19. Tan DX, Chen LD, Poeggeler B, et al. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocr J 1993 1 : 57 60.
20. Peyrot F, Ducrocq C. Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen species. J Pineal Res 2008 45 : 235 246.
21. Hardeland R, Tan DX, Reiter RJ. Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res 2009 47 : 109 126.
22. Reiter RJ, Paredes SD, Manchester LC, et al. Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol 2009 44 : 175 200.
23. Reiter RJ, Calvo JR, Karbownik M, et al. Melatonin and its relation to the immune system and inflammation. Ann N Y Acad Sci 2000 917 : 376 386.
24. Rosales-corral S, Tan DX, Reiter RJ, et al. Orally administered melatonin reduces oxidative stress and pro-inflammatory cytokines induced by amyloid-β peptide in rat brain: a comparative, in vivo study versus vitamin C and E. J Pineal Res 2003 35 : 80 84.
25. Pappolla M, Bozner P, Soto C, et al. Inhibition of Alzheimer's beta-fibrillogenesis by melatonin. J Biol Chem 1998 27 : 7185 7188.
26. Reiter RJ. The pineal gland and melatonin in relation to aging: a summary of the theories and of the data. Exp Gerontol 1995 30 : 199 212.
27. Stoppini L, Buchs PA, Muller D. A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 1991 37 : 173 182.
28. Bruce AJ, Makfroy B, Baudry M. β-amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger. Proc Natl Acad Sci U S A 1996 93 : 2312 2316.
29. Valentim LM, Rodnight R, Geyer AB, et al. Changes in heat shock protein 27 phosphorylation and immunocontent in response to preconditioning to oxygen and glucose deprivation in organotypic hippocampal cultures. Neuroscience 2003 118 : 379 386.
30. Horn AP, Frozza RL, Grudzinski PB, et al. Conditioned medium from mesenchymal stem cells induces cell death in organotypic cultures of rat hippocampus and aggravates lesion in a model of oxygen and glucose deprivation. Neurosci Res 2009 63 : 35 41.
31. Nassif M, Hoppe J, Santin K, et al. β-amyloid peptide toxicity in organotypic hippocampal slice culture involves Akt/PKB, GSK-3β, and PTEN. Neurochem Int 2007 50 : 229 235.
32. 25-35 toxicity in organotypic hippocampal slice cultures. Neurochem Res 2009 34 : 295 303.
33. Lee CC, Kuo YM, Huang CC, et al. Insulin rescues amyloid β-induced impairment of hippocampal long-term potentiation. Neurobiol Aging 2009 30 : 377 387.
34. Han YS, Zheng WH, Basttianetto S, et al. Neuroprotective effects of resveratrol against β-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br J Pharmacol 2004 141 : 997 1005.
35. Noraberg J, Kristensen BW, Zimmer J. Markers for neuronal degeneration in organotypic slice cultures. Brain Res Protocols 1999 3 : 278 290.
36. Macklis JD, Madison RD. Progressive incorporation of propidium iodide in cultured mouse neurons correlates with declining electrophysiological status: a fluorescence scale of membrane integrity. J Neurosci Methods 1990 31 : 43 46.
37. Peterson GL. Review of the folin-phenol protein quantification method of Lowry, Rosebrough, Farr and Randall. Anal Biochem 1979 100 : 201 220.
38. Yankner BA, Dawes LR, Fisher S, et al. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 1990 245 : 417 420.
39. Laferla FM, Green KN, Oddo S. Intracellular β-amyloid in Alzheimer's disease. Nat Neurosci 2007 8 : 499 509.
40. 42 Mutants with different aggregation profiles induces distinct pathologies in Drosophila. PloS ONE 2008 3 : e1703.
41. Refolo LM, Fillit HM. New directions in neuroprotection: basic mechanisms, molecular targets and treatment strategies. J Alzheimers Dis 2004 6 : S1 S2.
42. 25-35 induces presynaptic changes in organotypic hippocampal slice cultures. Neurotoxicology 2008 29 : 691 699.
43. Frotscher M, Zafirov S, Heimrich B. Development of identified neuronal types and of specific synaptic connection in slice cultures of rat hippocampus. Prog Neurobiol 1995 45 : 143 164.
44. Clapp-lilly KL, Smith MA, Perry G, et al. Melatonin acts as antioxidant and pro-oxidant in an organotypic slice culture model of Alzheimer's disease. Neuroreport 2001 12 : 1277 1280.
45. 25-35-induced apoptosis in mouse microglial BV2 cells. Neurosci Lett 2005 380 : 26 31.
46. Wang Y, Li X, Liu S, et al. Melatonin ameliorated okadaic-acid induced Alzheimer-like lesions. Acta Pharmacol Sin 2004 25 : 276 280.
47. Avila J, Santa-maría I, Pérez M, et al. Tau phosphorylation, aggregation, and cell toxicity. J Biomed Biotechnol 2006 1 : 1 5.
48. Sengupta A, Grundke-iqbal I, Iqbal K. Regulation of phosphorylation of tau by protein kinases in rat brain. Neurochem Res 2006 31 : 1473 1480.
49. Li XC, Wang ZF, Zhang JX, et al. Effect of melatonin on calyculin A-induced tau hyperphosphorylation. Eur J Pharmacol 2005 510 : 25 30.
50. Yin J, Liu YH, Xu YF, et al. Melatonin arrests peroxynitrite-induced tau hyperphosphorylation and the overactivation of protein kinases in rat brain. J Pineal Res 2006 41 : 124 129.
51. Takashima A, Honda T, Yasutake K, et al. Activation of tau protein kinase I/glycogen synthase kinase 3β by amyloid β peptide (25-35) enhances phosphorylation of tau in hippocampal neurons. Neurosci Res 1998 31 : 317 323.
52. Mazanetz MP, Fischer PM. Untangling tau hyperphosphorylation in drug design for neurodegenerative disease. Nat Rev 2007 6 : 464 479.
53. Ryder J, Su Y, Ni B. Akt/GSK3β serine/threonine kinases: evidence for a signaling pathway mediated by familial Alzheimer's disease mutations. Cell Signal 2004 16 : 187 200.
54. Zheng WH, Bastianetto S, Mennicken F, et al. Amyloid β peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures. Neuroscience 2002 115 : 201 211.
55. Tan J, Town T, Mori T, et al. CD45 opposes β-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activated protein kinase. J Neurosci 2000 20 : 7587 7594.
56. Combs CK, Karlo JC, Kao SC, et al. β-amyloid stimulation of microglia and monocytes results in TNFα-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci 2001 21 : 1179 1188.
57. Chan SF, Sucher NJ. An NMDA receptor signaling complex with protein phosphatase 2A. J Neurosci 2001 21 : 7985 7992.
58. Pike CJ, Cummmings BJ, Cotman CW. Early association of reactive astrocytes with senile plaques in Alzheimer's disease. Exp Neurol 1995 132 : 172 179.
59. Zaheer A, Zaheer S, Thangavel R, et al. Glia maturation factor modulates β-amyloid-induced glial activation, inflammmatory cytokine/chemokine production and neuronal damage. Brain Res 2008 1208 : 192 203.
60. Apelt J, Schliebs R. β-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenicTG2576 mice with Alzheimer plaque pathology. Brain Res 2001 894 : 21 30.
61. Xie Z, Smith CJ, Van eldik LJ. Acitivated glia induces neuron death via MAP kinase signaling pathways involving JNK and p38. Glia 2004 45 : 170 179.
62. Logpré F, Garneau P, Christen Y, et al. Protection by EGb 761 against beta-amyloid-induced neurotoxicity: involvement of NF-kappaB, SIRT1, and MAPKs pathways and inhibition of amyloid fibril formation. Free Radic Biol Med 2006 41 : 1781 1794.
63. Rosales-corral S, Tan DX, Reiter RJ, et al. Kinetics of the neuroinflammation-oxidative stress correlation in rat brain following the injection of fibrillar amyloid-β onto the hippocampus in vivo. J Neuroimmunol 2004 150 : 20 28.
64. Sribanek Z, Baláspiri L, Mák M. Interaction between synthetic amyloid-beta-peptide (1-40) and its aggregation inhibitors studied by electrospray ionization mass spectrometry. J Mass Spectrom 2001 36 : 1226 1229.
65. 1-42 in cortical neuron-glia cultures. Brain Res 2008 1188 : 139 147.